Rare infant brain tumors under the microscope: 20-Year french study completed
NCT ID NCT03115164
First seen Jun 19, 2026 · Last updated Jun 22, 2026 · Updated 1 time
Summary
This completed study reviewed 37 cases of rare brain tumors (DIA/DIG) in infants treated in French hospitals over 20 years. Researchers analyzed medical records and tumor samples to see why some tumors stay benign while others turn aggressive. The goal is to find clues that could improve future diagnosis and treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTROCYTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could help doctors better predict which DIA/DIG tumors will turn aggressive, guiding treatment decisions.
What could go wrong
This is a small, retrospective study (37 patients) that only looks at past data. It cannot prove new treatments or change care directly.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.